scholarly article | Q13442814 |
P356 | DOI | 10.1002/EJHF.820 |
P8608 | Fatcat ID | release_5jnr4lz3lzez5lx62ib5sx5fa4 |
P698 | PubMed publication ID | 28386910 |
P50 | author | Piotr Ponikowski | Q22114836 |
Waldemar Banasiak | Q68692977 | ||
Dirk J van Veldhuisen | Q82060328 | ||
Adriaan A Voors | Q91537232 | ||
Cristina Enjuanes-Grau | Q98904699 | ||
Piotr Rozentryt | Q114410470 | ||
Ewa A Jankowska | Q40395675 | ||
Michał Tkaczyszyn | Q59690884 | ||
Lech Poloński | Q68692844 | ||
P2093 | author name string | Josep Comín-Colet | |
Peter van der Meer | |||
Pedro Moliner-Borja | |||
P2860 | cites work | The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? | Q24685741 |
Disorders of iron metabolism | Q28141020 | ||
Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. | Q34041875 | ||
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib | Q34677347 | ||
Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency | Q36111521 | ||
Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study | Q36222401 | ||
Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options | Q36485489 | ||
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives | Q36682182 | ||
Iron status in patients with chronic heart failure | Q36971596 | ||
Iron regulation and erythropoiesis | Q37129637 | ||
Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency | Q77601954 | ||
The red cell indices in the diagnosis of iron-deficiency anemia | Q78544230 | ||
Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival | Q84917372 | ||
Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status | Q37195233 | ||
Anemia and chronic heart failure implications and treatment options. | Q37237844 | ||
Quality counts: new parameters in blood cell counting | Q37488024 | ||
Detection, evaluation, and management of iron-restricted erythropoiesis | Q37786455 | ||
Iron and erythropoiesis: a dual relationship | Q37822300 | ||
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches | Q37883005 | ||
Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis | Q37986258 | ||
Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis | Q38048880 | ||
Iron Deficiency in Heart Failure: Looking Beyond Anaemia | Q38669956 | ||
Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials | Q38715116 | ||
Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial | Q42646839 | ||
Ferric carboxymaltose in patients with heart failure and iron deficiency | Q43240282 | ||
Iron deficiency in chronic heart failure: an international pooled analysis | Q46257022 | ||
Iron deficiency: an ominous sign in patients with systolic chronic heart failure | Q48155909 | ||
Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure | Q48402812 | ||
Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure | Q48716818 | ||
Etiology of anemia in patients with advanced heart failure. | Q50711526 | ||
Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis | Q51114270 | ||
Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency. | Q51659287 | ||
Reticulocyte hemoglobin measurement--comparison of two methods in the diagnosis of iron-restricted erythropoiesis. | Q51962040 | ||
The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences | Q57911412 | ||
Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure | Q57911477 | ||
P921 | main subject | iron deficiency | Q1313081 |
P577 | publication date | 2017-04-06 | |
P1433 | published in | European Journal of Heart Failure | Q5017954 |
P1476 | title | Iron deficiency and red cell indices in patients with heart failure |